Allarity Therapeutics Inc share price logo

Allarity Therapeutics Inc Share Price

NASDAQ: ALLR

Small Cap

$1.17

+0.04

(+3.54%)

as on

Allarity Therapeutics Inc Stock Performance

as on April 3, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.12
    $1.19
    downward going graph

    4.27%

    Downside

    1.71%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.61
    $2.35
    downward going graph

    47.54%

    Downside

    100.85%

    Upside

    downward going graph

Allarity Therapeutics Inc share price movements today

Previous Close
$1.13
Open
$1.13
Volume
674.5K
Day's Low - High
$1.12 - $1.19
52 Week Low - High
$0.61 - $2.35

Allarity Therapeutics Inc Historical Returns

1 Month Return
+ 11.54 %
3 Month Return
+ 1.75 %
1 Year Return
+ 41.21 %
3 Year Return
-100 %
5 Year Return
0 %

Allarity Therapeutics Inc Stock Fundamentals & Key Indicators

Check Allarity Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$17.3M

EPS (TTM)

-0.85

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.21

Industry PE ratio

0

PEG Ratio

0

EBITDA

-17.1M

Revenue (TTM)

-7.1M

Profit Margin

0.00%

Return On Equity TTM

-150.58%

Allarity Therapeutics Inc Stock Valuation

Track how Allarity Therapeutics Inc P/E has moved over time to understand its valuation trends.

Allarity Therapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-44.14x)

September 30, 2023

Industry (0.00x)

April 3, 2026

Today (0.21x)

April 3, 2026

Highest (0.00x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 0.21x

Allarity Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Allarity Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Allarity Therapeutics Inc image
Allarity Therapeutics Inc
SELL$17.3MNA0.210.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.6B124.84%141.098.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.4BNA124.875.37%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$113.6B105.93%29.1632.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$82.2B60.41%18.7231.41%

Stock Returns calculator for Allarity Therapeutics Inc Stock including INR - Dollar returns

The Allarity Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Allarity Therapeutics Inc investment value today

Current value as on today

₹1,55,074

Returns

₹55,074

(+55.07%)

Returns from Allarity Therapeutics Inc Stock

₹42,683 (+42.68%)

Dollar Impact

₹12,391 (+12.39%)

Analyst Recommendation on Allarity Therapeutics Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Allarity Therapeutics Inc. Average target price of $9.25

Allarity Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Allarity Therapeutics Inc.

What analysts predicted

87.35%UPSIDE

Target Price

$9.25

Current Price

$1.17

Analyzed by

6 Analysts

Target

$9.25

Allarity Therapeutics Inc target price $9.25, a slight upside of 87.35% compared to current price of $1.17. According to 6 analysts rating.

Allarity Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Allarity Therapeutics Inc Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:13% versus previous 30 day period

Allarity Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
0
-
-
0
-
-
-
0
Gross Profit
0
0
0
0
0
0
0
0
-
-
Operating Income
-4
-4
-4
-3
-12
-7
-3
-4
-2
-2
EBITDA
-4
-4
-3
-1
-11
-7
-2
-2
-2
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-4
-1
-3
-1
-11
-7
-2
-2
-2
-3
Income Tax Expense
0
0
0
-
0
-
-
-
-
-
Net Income
-4
-1
-3
-1
-11
-7
-2
-2
-2
7
Net Profit Margin
0.00%
-1537.50%
-3431.25%
0.00%
0.00%
-124216.67%
0.00%
0.00%
0.00%
2455.63%

Allarity Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
1
1
0
-
-
-
-
-
0
Gross Profit
0
0
-3
0
0
0
0
0
0
-
Operating Income
-4
-3
-4
-17
-8
-26
-34
-17
-27
-12
EBITDA
-4
-3
-4
-15
-6
-25
-17
-11
-24
-12
Interest Expense
0
0
0
3
0
0
0
0
0
0
Depreciation
-
-
-
0
0
0
0
0
0
-
Income Before Tax
-4
-4
-3
-18
-6
-26
-17
-11
-24
-11
Income Tax Expense
0
0
-1
-4
0
0
-1
0
0
-
Net Income
-3
-4
-2
-14
-6
-26
-16
-11
-24
-11
Net Profit Margin
-2570.36%
-335.69%
-156.97%
-11927.50%
0.00%
0.00%
0.00%
0.00%
0.00%
-3509.69%

Allarity Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-1
-3
-1
-11
-7
-2
-2
-2
7
Operating Cash Flow
-1
-1
-7
-5
-3
-2
-5
-3
11
Investing Cash Flow
0
0
-
-
0
-
-
-
0
Financing Cash Flow
0
1
26
4
4
11
-2
2
0
Change in Cash
-1
0
18
0
1
8
-9
0
-16

Allarity Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-2
-14
-5
-26
-16
-11
-24
-
Operating Cash Flow
-1
-4
-10
-7
-15
-16
-12
-17
-
Investing Cash Flow
0
1
0
0
1
0
-
0
0
Financing Cash Flow
1
2
11
6
33
-1
10
36
10
Change in Cash
-1
0
1
-1
19
-17
-1
19
-4

Global Institutional Holdings in Allarity Therapeutics Inc

Funds
Holdings
Geode Capital Management, LLC
0.97%
Private Advisor Group, LLC
1.73%
Two Sigma Investments LLC
0.17%
Goldman Sachs Group Inc
0%
TWO SIGMA SECURITIES, LLC
0.08%
See all

Insights on Allarity Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ALLR has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Allarity Therapeutics Inc has experienced a drawdown of -100.0%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 92.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ALLR stock has moved down by -100.0%

About Allarity Therapeutics Inc

oncology venture is a drug development company formed in 2012 dedicated to unlock the potential of new oncology products, and rescue failed drugs. our method improves the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and improve success rates in oncology drug development.
OrganisationAllarity Therapeutics Inc
Headquarters24 School Street, Boston, MA, United States, 02108
CEOMr. Thomas H. Jensen
E-voting on sharesClick here to vote

Key Management of Allarity Therapeutics Inc

Name

Title

Dr. Steen Meier Knudsen Ph.D.

Founder & Chief Scientific Officer

Mr. Jeffrey S. Ervin M.B.A.

Chief Financial Officer

Dr. Jose L. Iglesias M.D.

Consultant Chief Medical Officer

Mr. Thomas H. Jensen

Founder, CEO & Director

Dr. Jeremy R. Graff Ph.D.

President & Chief Development Officer

FAQs

What is Allarity Therapeutics Inc share price today?

Allarity Therapeutics Inc share price today is $1.17 as on at the close of the market. Allarity Therapeutics Inc share today touched a day high of $1.19 and a low of $1.12.

What is the 52 week high and 52 week low for Allarity Therapeutics Inc share?

Allarity Therapeutics Inc share touched a 52 week high of $2.35 on and a 52 week low of $0.61 on . Allarity Therapeutics Inc stock price today i.e. is closed at $1.17,which is 50.21% down from its 52 week high and 90.62% up from its 52 week low.

What is Allarity Therapeutics Inc's market capitalisation today?

Allarity Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Allarity Therapeutics Inc Stock (ALLR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Allarity Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Allarity Therapeutics Inc Shares that will get you 1.2821 shares as per Allarity Therapeutics Inc share price of $1.17 per share as on April 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Allarity Therapeutics Inc Stock (ALLR) from India?

Indian investors can start investing in Allarity Therapeutics Inc (ALLR) shares with as little as ₹92.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.80 in Allarity Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Allarity Therapeutics Inc share’s latest price of $1.17 as on April 3, 2026 at 1:29 am IST, you will get 8.5470 shares of Allarity Therapeutics Inc. Learn more about fractional shares .